Impact of CPAP treatment on the changes of maxi-k+ channel beta subunit-1 expression in patients affected by sleep apnea-hypopnea syndrome (SAHS)

C. Caballero, A. Sanchez Armengol, M.J. Dominguez-Simeón, M. Abad, C. Carmona, P. Stiefel, F. Capote (Seville, Spain)

Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Session: Cardiovascular disease and sleep-disordered breathing
Session type: Oral Presentation
Number: 3292
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Caballero, A. Sanchez Armengol, M.J. Dominguez-Simeón, M. Abad, C. Carmona, P. Stiefel, F. Capote (Seville, Spain). Impact of CPAP treatment on the changes of maxi-k+ channel beta subunit-1 expression in patients affected by sleep apnea-hypopnea syndrome (SAHS). Eur Respir J 2012; 40: Suppl. 56, 3292

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CPAP versus CPAP plus low dose of PDE-inhibitor in men with obstructive sleep apnea-hypopnea syndrome (OSAHS) and erectile dysfunction (ED)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010


Reliability of apnea/hypopnea index (AHI) determined by two different auto-CPAP in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011


Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003

Prevalence of residual sleepiness in patients with optimally treated sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 724s
Year: 2005

PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012

Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 216s
Year: 2006

Comparison of residual apnea-hypopnea index given by positive airway pressure software and polysomnography in patients with sleep apnea syndrome.
Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Year: 2019

Effects of a 30º and 60º sleep position on sleep quality, snoring and apnoea/hypopnoea (AHI) index in patients with mild obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 642s
Year: 2006

The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Does PAP treatment in obstructive sleep apnea (OSA) patients change functional MRI activation?
Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea
Year: 2008

Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

CPAP induces structural changes in the inspiratory muscles of patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 222s
Year: 2002

Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome?
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 216s
Year: 2001

Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Impact of a respiratory rehabilitation program in the functional capacity of the patients with obstructive sleep apnea-hypopnea syndrome (OSAHS)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005

Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010